Skip to Main Content

Imaging dopamine mediated effects of stress on inhibitory control

Conditions

Diseases of the Nervous System

What is the purpose of this trial?

You are invited to take part in our research study of the brain, the immune system, and  cigarette smoking. We will use brain imaging (PET and MRI) to determine if activation of the immune system leads to greater chance of relapse to smoking. After agreeing to participate in this research, you will receive a low dose of either lipopolysaccharide (LPS) or placebo on scan days and methylphenidate (Ritalin) on PET scan days. There are three PET scans and two MRI scans.

  • Trial with
    National Institute on Drug Abuse (NIDA)
  • Start Date
    10/29/2018
  • End Date
    02/28/2023
Trial Image

For more information about this study, contact:

Jon Mikael Anderson

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    09/18/2019
  • Study HIC
    #2000023863